The Importance of End-to-End Quality Control Processes for RNA Biomarker Discovery
Speakers: Cheryl Sesler, MS, Decode Health, Inc., United States, Dr. Annika Dorn, Agilent Technologies, Germany, Lawrence Howes, SelectScienceCheryl Sesler, MS, Decode Health, Inc., United States · Dr. Annika Dorn, Agilent Technologies, Germany · Lawrence Howes, SelectScienceCheryl Sesler, MS, Decode Health, Inc., United StatesDr. Annika Dorn, Agilent Technologies, GermanyLawrence Howes, SelectScience · · +1 more · +2 more · +3 more
Watch on demand